PNC Financial Services Group Inc. Decreases Stake in The Cooper Companies, Inc. $COO

PNC Financial Services Group Inc. lessened its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 17.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,736 shares of the medical device company’s stock after selling 13,466 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Cooper Companies were worth $4,438,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of Cooper Companies by 1.8% in the second quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company’s stock valued at $1,725,963,000 after purchasing an additional 421,423 shares in the last quarter. State Street Corp lifted its position in Cooper Companies by 1.2% during the second quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock valued at $616,227,000 after purchasing an additional 104,910 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Cooper Companies by 2.5% in the 2nd quarter. Geode Capital Management LLC now owns 5,205,615 shares of the medical device company’s stock worth $368,893,000 after buying an additional 127,907 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in shares of Cooper Companies by 98.8% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after buying an additional 1,683,561 shares during the last quarter. Finally, Sustainable Growth Advisers LP bought a new stake in shares of Cooper Companies in the 2nd quarter worth about $240,881,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Wells Fargo & Company lifted their price target on Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a research report on Friday, December 5th. Stifel Nicolaus set a $95.00 price objective on Cooper Companies and gave the company a “buy” rating in a research note on Friday, December 5th. Morgan Stanley lifted their target price on Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a report on Monday, December 8th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a report on Friday, December 5th. Finally, Weiss Ratings upgraded Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $90.77.

Cooper Companies Stock Performance

Shares of COO stock opened at $84.07 on Friday. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $92.84. The business’s fifty day simple moving average is $82.12 and its 200-day simple moving average is $75.21. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The company has a market cap of $16.48 billion, a PE ratio of 44.72, a PEG ratio of 2.39 and a beta of 1.03.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the previous year, the business earned $1.04 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Albert G. White III acquired 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 16th. The stock was purchased at an average cost of $80.80 per share, with a total value of $808,000.00. Following the transaction, the chief executive officer directly owned 236,151 shares of the company’s stock, valued at $19,081,000.80. This trade represents a 4.42% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Lawrence Erik Kurzius bought 2,000 shares of the company’s stock in a transaction on Wednesday, December 17th. The shares were bought at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the transaction, the director owned 7,777 shares in the company, valued at $641,602.50. The trade was a 34.62% increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders have acquired 16,014 shares of company stock valued at $1,304,416. 1.98% of the stock is owned by company insiders.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.